Crossmark

ASO Author Reflections: The Increasing Role of Locoregional Therapy in Advanced Hepatocellular Carcinomas

Published Online: 2024-11-26

Published Print: 2025-03

Authors

Yan, Michael https://orcid.org/0000-0002-8387-6563
Li, Zhihao

Dawson, Laura A.

Sapisochin, Gonzalo
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 12 November 2024

Accepted: 13 November 2024

First Online: 26 November 2024

Disclosure

: Gonzalo Sapisochin has been a consultant for Astra-Zeneca, Roche, Evidera, Novartis, HepaRegenix, and Integra. He has received financial compensation for talks for Roche, Astra-Zeneca, Chiesi, and Integra, and has received research funding from Roche and Astra-Zeneca. Laura A. Dawson received funding from Merck for a grant (monies to institution) and has received honorarium from Astra-Zeneca. She was the PI of the RTOG 1112 trial. Michael Yan has been a consultant for Need Inc. Zhihao Li has no conflicts of interest.

Document is current